How have CHEOF shares performed in 2024?

Cochlear's stock was trading at $198.50 on January 1st, 2024. Since then, CHEOF shares have increased by 5.3% and is now trading at $209.00. View the best growth stocks for 2024 here .

Is Cochlear a good dividend stock?

Cochlear (OTCMKTS:CHEOF) pays an annual dividend of $1.27 per share and currently has a dividend yield of 2.07%. The dividend payout ratio is 77.34%. Payout ratios above 75% are not desirable because they may not be sustainable.

How do I buy shares of Cochlear?

Shares of CHEOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:CHEOF

Cochlear (CHEOF) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free CHEOF Stock Alerts

$209.00

-1.00 (-0.48%)

(As of 04/18/2024 11:30 AM ET)

Compare

Today's Range: $209.00
▼
$209.00
50-Day Range: $205.54
▼
$230.46
52-Week Range: $145.73
▼
$230.46

Volume: 1 shs
Average Volume: 168 shs
Market Capitalization: N/A

P/E Ratio: 127.28
Dividend Yield: 0.61%
Price Target: N/A

Stock Analysis Chart Financials Headlines SEC Filings Short Interest

Get Cochlear alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Cochlear Stock (OTCMKTS:CHEOF)

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

CHEOF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CHEOF Stock News Headlines

April 19, 2024 | americanbankingnews.com

Cochlear (OTCMKTS:CHEOF) Stock Price Down 0.5%

July 26, 2023 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Terns Pharmaceuticals (TERN) and Cochlear Limited (OtherCHEOF)

April 19, 2024 | InvestorPlace (Ad)

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

July 20, 2023 | msn.com

Chandy’s Cochlear Implant Scheme hits hurdles, parents seek government help

July 19, 2023 | benzinga.com

Sensorion Submits Clinical Trial Application for OTOF-GT, its Lead Gene Therapy Candidate, in Europe

July 18, 2023 | msn.com

7-year-old girl hears for first time after Chhattisgarh govt sponsors operation, father wants her to become doctor

July 18, 2023 | msn.com

Oommen Chandy: Humane leader who put patients first, say health experts

July 10, 2023 | markets.businessinsider.com

Morgan Stanley Keeps Their Hold Rating on Cochlear Limited (CHEOF)

April 19, 2024 | InvestorPlace (Ad)

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

July 10, 2023 | benzinga.com

Sensorion Submits Clinical Trial Application for Lead Gene Therapy Candidate OTOF-GT in the UK

July 5, 2023 | benzinga.com

Sensorion Reports Positive Efficacy Data from SENS-401 Phase 2a Clinical Study

June 25, 2023 | msn.com

Rajasthan: Govt announces ₹1 lakh airfare for travel for organ transplant

June 25, 2023 | thetimes.co.uk

NHS may have missed thousands of deaf children in ‘huge national failure’

June 22, 2023 | morningstar.com

FTSE 100 Closes Down 0.75% After Rate Hike; Ocado Surges on Bid Speculation

June 22, 2023 | afr.com

Labor bows to pressure on multinational tax disclosure

June 19, 2023 | finance.yahoo.com

Sensorion Reports Promising Preliminary Data from SENS-401 Phase 2a Clinical Study

May 22, 2023 | afr.com

‘Next Cochlear’ stock surges after heart device breakthrough

May 4, 2023 | marketwatch.com

Cochlear Implants Market Share | Business till 2030

May 3, 2023 | msn.com

Parents to inform SA cochlear implant review

April 20, 2023 | msn.com

Townsville University Hospital staff stood down amid review of paediatric audiology unit outcomes

April 16, 2023 | afr.com

Australian business delegation heads to China

April 11, 2023 | msn.com

Surgeries of chronically ill children in Pune pending under RBSK

April 6, 2023 | marketwatch.com

Cochlear Implant (CI) Systems Market 2023-2030| Expert Analysis of Current Trend and Scope to Drive the Market

April 6, 2023 | marketwatch.com

Sensorion Announces Candidate Selection for GJB2 Gene Therapy Program

March 22, 2023 | uk.news.yahoo.com

Dad runs half marathon to help deaf babies like his son

March 22, 2023 | nasdaq.com

Cochlear, Demant contest UK regulator's Oticon deal concerns

March 21, 2023 | markets.businessinsider.com

Dr. Jace Wolfe named Senior Vice President at Oberkotter Foundation - Hearing First

See More Headlines

Receive CHEOF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Medical Devices
Sub-Industry: N/A
Current Symbol: OTCMKTS:CHEOF
CUSIP: N/A
CIK: 1453930
Web: www.cochlear.com
Phone: (129) 428-6555
Fax: N/A
Employees: 4,800
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 127.28
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Mr. Diggory William Howitt BE (Hons) (Age 57)
MBA, CEO, MD, President & Executive Director
Comp: $3.1M
Mr. Stuart Sayers
Chief Financial Officer
Mr. Jan Janssen MSc Elec Eng (Age 59)
Chief Technology Officer
Comp: $1.32M
Ms. Karen O'Driscoll
Chief Information Officer
Ms. Kristina Devon
Vice President of Investor Relations
Rob McGrory
Group General Counsel
Ms. Jennifer Stevenson
VP of Corporate Communications & Brand
Mr. Dean Phizacklea
Senior Vice President of Global Strategic Marketing
Ms. Jennifer Hornery
Senior Vice President of Global People & Culture
Mr. Greg Bodkin BE (Hons)
MComm (UNSW), Senior Vice President of Global Supply Chain

Key Competitors

View All Competitors

CHEOF Stock Analysis - Frequently Asked Questions

How have CHEOF shares performed in 2024?: Cochlear's stock was trading at $198.50 on January 1st, 2024. Since then, CHEOF shares have increased by 5.3% and is now trading at $209.00.
View the best growth stocks for 2024 here.
Is Cochlear a good dividend stock?: Cochlear (OTCMKTS:CHEOF) pays an annual dividend of $1.27 per share and currently has a dividend yield of 2.07%. The dividend payout ratio is 77.34%. Payout ratios above 75% are not desirable because they may not be sustainable.
How do I buy shares of Cochlear?: Shares of CHEOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CHEOF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial